Financial Advisory Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-625
| Closed | -$11K | – | 65 |
|
|
2016
Q3 | $11K | Hold |
625
| – | – | ﹤0.01% | 63 |
|
|
2016
Q2 | $7K | Buy |
625
+125
| +25% | +$1.4K | ﹤0.01% | 59 |
|
|
2016
Q1 | $356K | Hold |
500
| – | – | 0.17% | 44 |
|
|
2015
Q4 | $13K | Hold |
500
| – | – | 0.01% | 59 |
|
|
2015
Q3 | $23K | Sell |
500
-125
| -20% | -$5.75K | 0.01% | 51 |
|
|
2015
Q2 | $20K | Hold |
625
| – | – | 0.01% | 50 |
|
|
2015
Q1 | $20K | Hold |
625
| – | – | 0.01% | 49 |
|
|
2014
Q4 | $24K | Buy |
625
+125
| +25% | +$4.8K | 0.01% | 48 |
|
|
2014
Q3 | $13K | Hold |
500
| – | – | 0.01% | 53 |
|
|
2014
Q2 | $15K | Buy |
+500
| New | +$15K | 0.01% | 54 |
|
|
2013
Q4 | – | Sell |
-500
| Closed | -$27K | – | 54 |
|
|
2013
Q3 | $27K | Buy |
+500
| New | +$27K | 0.02% | 46 |
|